Navigation Links
Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients
Date:8/4/2008

BETOL combination trial, the incidence of serious adverse events was 17% in the PEGINTRON/REBETOL groups compared to 14% in the INTRON A/ REBETOL group. The incidence of severe adverse events in the PEGINTRON/REBETOL combination therapy trial was 23% in the INTRON A/REBETOL group and 31-34% in the PEGINTRON/REBETOL groups. Dose reductions due to adverse reactions occurred in 42% of patients receiving PEGINTRON (1.5 mcg/kg)/REBETOL and in 34% of those receiving INTRON A/REBETOL.

In a study with weight-based ribavirin, there was a higher rate of anemia among patients in the weight-based dosing group (29%) compared to the flat-dosing group (19%). The majority of these cases were mild and responded to dose reductions. Serious adverse events were similar between the two groups (12%), and discontinuations for adverse events (15% in weight-based dosing and 14% in flat dosing) were also similar. Dose modifications due to adverse events occurred more frequently in the weight-based dosing group (29%) compared to the flat-dosing (23%) group.

Additional Safety Information

Relapse of drug addiction/overdose has occurred in patients on PEGINTRON therapy. Aggressive behavior sometimes directed towards others has occurred in patients with and without a previous psychiatric disorder during PEGINTRON and/or INTRON A treatment and follow-up. If patients develop psychiatric problems, including clinical depression, it is recommended that patients be carefully monitored during treatment and in the 6-month follow-up period. If psychiatric symptoms persist or worsen, or suicidal ideation or aggressive behavior towards others is identified, it is recommended that treatment with PEGINTRON and/or INTRON A be discontinued, and the patient be carefully followed with psychiatric intervention, as appropriate. Cases of encephalopathy have been observed in some patients, usually elderly, treated with higher doses of PEGINTRON and/or INTRON A. Ischemic and hemorrhagic cerebrovas
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
2. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
3. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
4. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
5. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
6. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
7. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
8. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
9. Schering-Plough Reports Top-Line Results of the IDEAL Study
10. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
11. Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 PuraMed BioScience ® , Inc., ... (OTC) medicinal and healthcare products, announced today that ... along with the name,s red and yellow logo. ... name MigraPure ®  going forward. The new ... natural migraine pain reliever will be reintroduced into ...
(Date:7/30/2014)... DUBLIN , July 30, 2014 ... the "Global and Chinese Aseptic Packaging Industry Report ... http://photos.prnewswire.com/prnh/20130307/600769 The Global and ... in-depth study on the current state of the global ... situation. The report provides a basic overview of ...
(Date:7/30/2014)... , July 30, 2014 Stryker brand ambassadors Fred ... at the 3M Championship Champions Tour event near Minneapolis, ... Blaine . Stryker is the official joint replacement ... Starting Friday, August 1 st through Sunday, August 3 ... Zone; an on-site joint health destination located in the Pioneer Press ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Global and Chinese Aseptic Packaging Industry Report 2014 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5
... May 24, 2011 Reportlinker.com announces that ... in its catalogue: Triple ... http://www.reportlinker.com/p0284621/Triple-Analysis-Leukemia-Lymphoma-and-Peptides.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology This ... strategies in both Leukemia and Lymphoma and ...
... Calif., May 23, 2011 Applied Medical today announced ... business as Covidien) on May 17, 2011 in the ... for infringing a recently issued Applied Medical trocar seal ... products, Civil Action No. CV 11-4203 VBF (AJWx). The ...
Cached Medicine Technology:Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides 2Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides 3Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides 4Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides 5Applied Medical Sues Covidien, Asserting Recently Issued Universal Seal Trocar Patent 2
(Date:7/31/2014)... 2014 “Bivalent, Heteronomy and Natural Killer ... hottest metal bands ~ homeostatic CS science is the ... July Roundup, new on the Bryan William Brickner ... and the cannabinoid system (CS). The line-up links to ... wellness: three directly on homeostasis, two each on the ...
(Date:7/31/2014)... latest blog post, Best Drug Rehabilitation , which offers ... a stay in rehab can make a big difference in ... nine secrets that addicts don’t want others to know. ... addict from a mile away, and totally understand what’s going ... Per Wickstrom . “However, take it from me: spotting addicts ...
(Date:7/31/2014)... 31, 2014 Continuing Education Company ... inaugural Clinical Issues in Primary Care Continuing ... 2014 at the Wailea Beach Marriott Resort and Spa ... has been developed for today's Primary Care practitioners. In ... topics," says Barbara Lyons, VP Education. , The agenda ...
(Date:7/30/2014)... Denver, Colorado (PRWEB) July 30, 2014 ... the skiers wearing orange vests emblazoned with “Blind Skier.” ... Colorado slopes through Foresight Ski Guides , a ... with visually impaired and blind participants (VIPs) for snow ... interested in guiding can learn more and pick up ...
(Date:7/30/2014)... July 31, 2014 Responding to ... environment more responsive to an increasingly diverse patient ... experience and scholarly expertise to the publication of ... care professions: "Diversity and Cultural Competence in Health ... L. Dreachslin, PhD, a professor in the Management ...
Breaking Medicine News(10 mins):Health News:Homeostatic Cannabinoid Science ~ Publius’ July Roundup on the Bryan William Brickner Blog 2Health News:Latest Best Drug Rehabilitation Blog Posts Focuses on Nine Secrets Addicts Don’t Want Others to Know 2Health News:Latest Best Drug Rehabilitation Blog Posts Focuses on Nine Secrets Addicts Don’t Want Others to Know 3Health News:Clinical Issues in Primary Care Continuing Medical Education (CME) Conference - October 13-17, 2014 in Maui, Hawaii - Agenda Released 2Health News:Clinical Issues in Primary Care Continuing Medical Education (CME) Conference - October 13-17, 2014 in Maui, Hawaii - Agenda Released 3Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 3
... Health & Science University researchers have determined exactly how much ... results of this research are being presented from 5 p.m. ... for Therapeutic Radiology and Oncology in Boston. , "Many ... that it doesn,t move in relation to the bony pelvis, ...
... is playing an ever smaller role in the treatment ... and safe radiation therapy techniques. Progress in radiation technology ... This is according to Professor Freek Beekman, who will ... on Wednesday, 24 September. , In his inaugural ...
... bacteria that drive the ailment, study shows , , WEDNESDAY, ... sweet relief to chronic sinusitis sufferers, new Canadian research ... attack the bacteria that cause the discomforting disorder. , ... natural anti-microbial dressing for infected wounds for hundreds of ...
... 24 TransEnterix, an,early-stage, privately-held medical device company ... the Board of Directors has,named Todd M. Pope ... Pope has spent nearly 20 years in the ... neurovascular, and,laparoscopic surgery., Mr. Pope, 43, was ...
... Indianapolis speech, INDIANAPOLIS, Sept. 24 Today Eli ... is set to become the first,pharmaceutical research company to ... At a speech before the Economic Club of Indiana ... outlined the,company,s plans to launch an online registry of ...
... Longstanding Barriers to ... Hearing Better, ... a unique option for people dealing with mild to moderate,hearing loss. ... hearing loss, while concerns about cost,commitments, and inconvenience contribute to only ...
Cached Medicine News:Health News:OHSU Cancer Institute researchers study breathing during radiation 2Health News:Open cancer surgery set to become a thing of the past 2Health News:A Honey of a Sinusitis Treatment 2Health News:A Honey of a Sinusitis Treatment 3Health News:TransEnterix Inc. Names Experienced Medical Device Executive Todd M. Pope as President, CEO 2Health News:Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments 2Health News:Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments 3Health News:Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss 2Health News:Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss 3
The under-patient design of the pediatric full access blanket warms even the tiniest patients while allowing full access for surgeons and staff....
This blanket gently surrounds the child with temperature-controlled air. Use one or both of the enclosed clear plastic drapes to keep warmed air near the skin....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers....
The multi-access blanket offers access to any part of the patient's body while providing full patient coverage....
Medicine Products: